Oxygen Biotherapeutics, Inc. CEO to Ring Opening Bell at NASDAQ January 22
21 Januar 2010 - 3:00PM
PR Newswire (US)
DURHAM, N.C., Jan. 21 /PRNewswire-FirstCall/ -- Oxygen
Biotherapeutics, Inc. (NASDAQ:OXBT) chairman and CEO Chris Stern
will preside over the NASDAQ Opening Bell on Friday, January 22,
2010. A live webcast of the NASDAQ Opening Bell will be available
at: http://www.nasdaq.com/about/marketsitetowervideo.asx starting
at 9:20 a.m. eastern time. About Oxygen Biotherapeutics, Inc.
Oxygen Biotherapeutics, Inc. is dedicated to commercializing
innovative pharmaceuticals and medical devices in the field of
oxygen therapeutics and Defense Medicine(TM). The company has
developed a perfluorocarbon (PFC) therapeutic oxygen carrier and
liquid ventilation product (Oxycyte(TM)) and has out-licensed an
implantable glucose sensor. These products are based upon core
technologies that include biomedical applications for PFCs as well
as medical and industrial applications for biosensors. Each of the
product candidates is designed with advantages over currently
marketed products in major markets including traumatic brain
injury, sickle cell crisis, trauma, wound care, decompression
sickness, acute respiratory distress syndrome, stroke, myocardial
infarction, surgery, diabetes wounds and ulcers, and cosmetic
applications which are being marketed under the Dermacyte name.
More information is available at http://www.oxybiomed.com/.
DATASOURCE: Oxygen Biotherapeutics, Inc. CONTACT: Abe Wischnia of
Abe Wischnia & Associates, +1-619-795-2345, for Oxygen
Biotherapeutics, Inc. Web Site: http://www.oxybiomed.com/
Copyright